Avicena Demonstrates Breakthrough Ultra-Low Power microLED Link at 200fJ/bit Tx Power
Avicena Is Showcasing an Ultra-low Power microLED Interconnect at 200fJ/bit of Transmitter Power Using Optimized Camera Sensor as the Receiver COPENHAGEN, Denmark–(BUSINESS... Read more.
Kao Revamps Cosmetics Business Strategy to Accelerate Growth
Driving sustainable growth through focused investment in six brands and three overseas expansion models TOKYO–(BUSINESS WIRE)–On September 19, 2025,... Read more.
7-Eleven Philippines Selects Blue Yonder To Scale Its Store Operations
Philippines’ convenience retailer to implement Blue Yonder solution to enhance customer experience through innovation and technology MANILA, Philippines &... Read more.
Serco Asia Pacific Improves Integration Significantly Using Boomi AI Agents
Serco fast-tracks integration delivery with Boomi Scribe and DesignGen, significantly reducing integration documentation time SYDNEY–(BUSINESS WIRE)–Boomi™,... Read more.
Palantir Technologies Announces Two-Day Pop-Up Experience in Seoul
Two-day showcase in Seoul celebrates Korean fanbase with limited-edition company merchandise drops. DENVER–(BUSINESS WIRE)–Palantir Technologies will... Read more.
VITAL-HF Trial Demonstrates Remote Digital Intervention Safely Improves Guideline-Directed Therapy in Heart Failure Patients
Story Health by Innovaccer, a digital care platform evaluated in the VITAL-HF trial, demonstrates safe and significant improvements in heart failure therapy optimization.... Read more.
Varian Elevates Halcyon Platform by Redefining the Patient Experience
The new PerfectKinetix Dynamic Couch* accelerates patient positioning, and aims to improve comfort IDENTIFY* integration improves positioning options; automated... Read more.
Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer
Findings from the first prospective validation trial for biomarker presented at ASTRO 2025 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$VYCT #ASTRO25—Veracyte,... Read more.
New Data from HELIOS-B Phase 3 Study Demonstrate Lower Rates of Gastrointestinal Events in ATTR-CM Patients Treated with Vutrisiran
− Treatment with Vutrisiran Led to 37- 49% Lower Rates of Gastrointestinal Events, a Multisystem Manifestation of ATTR-CM, Across Multiple Treatment Groups, Compared... Read more.
Argonne Scientists Investigate 3D-Printed Steels for Use in Next-Generation Nuclear Reactors
LEMONT, Ill.–(BUSINESS WIRE)–Stainless steel has long been a workhorse material for the nuclear industry. It fortifies walls and forms crucial components... Read more.